210 related articles for article (PubMed ID: 23754654)
21. Recurrence and survival after mesorectal excision for rectal cancer.
Bülow S; Christensen IJ; Harling H; Kronborg O; Fenger C; Nielsen HJ; ;
Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551
[TBL] [Abstract][Full Text] [Related]
22. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice.
Dowdall JF; Maguire D; McAnena OJ
Br J Surg; 2002 Aug; 89(8):1014-9. PubMed ID: 12153627
[TBL] [Abstract][Full Text] [Related]
23. The development of a regional referral pathway for locally recurrent rectal cancer: A Delphi consensus study.
Denost Q; Bousser V; Morin-Porchet C; Vincent C; Pinon E; Collin F; Martin A; Colombani F; Digue L; Ravaud A; Harji DP; Saillour-Glénisson F
Eur J Surg Oncol; 2020 Mar; 46(3):470-475. PubMed ID: 31866109
[TBL] [Abstract][Full Text] [Related]
24. Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx Collaborative.
PelvEx Collaborative
BJS Open; 2021 Jan; 5(1):. PubMed ID: 33609393
[TBL] [Abstract][Full Text] [Related]
25. Aggressive multimodality treatment for locally advanced irresectable rectal cancer.
Farouk R; Nelson H; Gunderson LL
Br J Surg; 1997 Jun; 84(6):741-9. PubMed ID: 9189078
[TBL] [Abstract][Full Text] [Related]
26. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
27. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
28. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer.
Glynne-Jones R; Mathur P; Elton C; Train ML
Best Pract Res Clin Gastroenterol; 2007; 21(6):1049-70. PubMed ID: 18070703
[TBL] [Abstract][Full Text] [Related]
29. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
30. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer.
Bhangu A; Brown G; Akmal M; Tekkis P
Br J Surg; 2012 Oct; 99(10):1453-61. PubMed ID: 22961529
[TBL] [Abstract][Full Text] [Related]
31. Session 3: Beyond the boundaries of Total Mesorectal Excision - where surgeons fear to tread.
Patel A; Holm T; Wale A; Rutten H; Nicholls J; Hawkins M; Steele RJC; Marks J; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():61-64. PubMed ID: 29878672
[TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy.
Lezoche E; Baldarelli M; Lezoche G; Paganini AM; Gesuita R; Guerrieri M
Br J Surg; 2012 Sep; 99(9):1211-8. PubMed ID: 22864880
[TBL] [Abstract][Full Text] [Related]
33. Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome.
Wiig JN; Larsen SG; Dueland S; Flatmark K; Giercksky KE
Colorectal Dis; 2011 May; 13(5):506-11. PubMed ID: 20236148
[TBL] [Abstract][Full Text] [Related]
34. [Progress of surgical managements in patients with local recurrent rectal cancer].
Jiang YM; Zhao R
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):597-600. PubMed ID: 23801218
[TBL] [Abstract][Full Text] [Related]
35. Preoperative decision making for rectal cancer.
Taflampas P; Christodoulakis M; de Bree E; Melissas J; Tsiftsis DD
Am J Surg; 2010 Sep; 200(3):426-32. PubMed ID: 20223450
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer.
Bikhchandani J; Ong GK; Dozois EJ; Mathis KL
Dis Colon Rectum; 2015 Mar; 58(3):283-7. PubMed ID: 25664705
[TBL] [Abstract][Full Text] [Related]
37. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
38. National and international guidelines for rectal cancer.
Nielsen LB; Wille-Jørgensen P
Colorectal Dis; 2014 Nov; 16(11):854-65. PubMed ID: 24888694
[TBL] [Abstract][Full Text] [Related]
39. European consensus on the standardization of robotic total mesorectal excision for rectal cancer.
Miskovic D; Ahmed J; Bissett-Amess R; Gómez Ruiz M; Luca F; Jayne D; Figueiredo N; Heald RJ; Spinoglio G; Parvaiz A;
Colorectal Dis; 2019 Mar; 21(3):270-276. PubMed ID: 30489676
[TBL] [Abstract][Full Text] [Related]
40. Preoperative staging of rectal cancer allows selection of patients for preoperative radiotherapy.
Horgan AF; Finlay IG
Br J Surg; 2000 May; 87(5):575-9. PubMed ID: 10792312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
